Chimerix

Chimerix, Inc. was a biopharmaceutical company headquartered in Durham, North Carolina, focused on developing medicines for serious and life-threatening diseases. It is best known for brincidofovir (TEMBEXA), an antiviral approved by the U.S. FDA in 2021 as a smallpox medical countermeasure, and for dordaviprone (ONC201), an investigational small-molecule therapy for H3 K27M-mutant diffuse glioma, a form of brain cancer. Chimerix was a publicly traded company (NASDAQ: CMRX) and was acquired by Jazz Pharmaceuticals in 2025, primarily for dordaviprone; the chimerix.com domain now redirects to jazzpharma.com. As a clinical-stage pharmaceutical company, Chimerix does not operate a public developer program or API surface — this profile tracks it as a company entity within the API Evangelist network.

Chimerix is profiled on the APIs.io network. Tagged areas include Company, Biopharmaceutical, Pharmaceuticals, Oncology, and Antivirals.

🌐 Visit website 📡 Source on GitHub

3.3/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-20 · rubric v0.12.0

0 APIs

Company Biopharmaceutical Pharmaceuticals Oncology Antivirals Life Sciences Clinical Stage

Kin Score

Kin Score How this is scored →
scored 2026-08-20 · rubric v0.12.0

Composite quality — 3.3/100 · minimal

Contract Quality 0.0 / 21

Developer Ergonomics 0.0 / 17

Access Clarity 0.0 / 17

Operational Transparency 0.0 / 11

Contract Governance 0.0 / 10

Discoverability 4.3 / 9

Regulatory Posture 1.1 / 15

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 10

Documented Reversibility 0 / 6

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

A2A Agent Card 0 / 8

Dry-Run / Simulate Mode 0 / 4

Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.

The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/chimerix: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Company 1

The organization behind the API

Website

Website

Source (apis.yml)

aid: chimerix
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/chimerix.png
name: Chimerix
description: 'Chimerix, Inc. was a biopharmaceutical company headquartered in Durham, North Carolina, focused on developing
  medicines for serious and life-threatening diseases. It is best known for brincidofovir (TEMBEXA), an antiviral approved
  by the U.S. FDA in 2021 as a smallpox medical countermeasure, and for dordaviprone (ONC201), an investigational small-molecule
  therapy for H3 K27M-mutant diffuse glioma, a form of brain cancer. Chimerix was a publicly traded company (NASDAQ: CMRX)
  and was acquired by Jazz Pharmaceuticals in 2025, primarily for dordaviprone; the chimerix.com domain now redirects to jazzpharma.com.
  As a clinical-stage pharmaceutical company, Chimerix does not operate a public developer program or API surface — this profile
  tracks it as a company entity within the API Evangelist network.'
url: https://raw.githubusercontent.com/api-evangelist/chimerix/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- canaan-partners
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.23'
created: '2026-07-17'
modified: '2026-07-18'
tags:
- Company
- Biopharmaceutical
- Pharmaceuticals
- Oncology
- Antivirals
- Life Sciences
- Clinical Stage
apis: []
common:
- type: DomainSecurity
  url: security/chimerix-domain-security.yml
- type: Website
  url: https://www.chimerix.com
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence

Chimerix

Kin Score

Security Posture 1

Chimerix Domain Security

Resources

Access & Security 1

Company 1

Source (apis.yml)